image
Healthcare - Biotechnology - NASDAQ - US
$ 9.16
-7.66 %
$ 1.43 B
Market Cap
-8.4
P/E
INCOME STATEMENT
58.4 M REVENUE
13.49%
-82.4 M OPERATING INCOME
-4.74%
-80.7 M NET INCOME
-13.65%
EFFICIENCY
Earnings Waterfall Ocular Therapeutix, Inc.
image
Revenue 58.4 M
Cost Of Revenue 5.28 M
Gross Profit 53.2 M
Operating Expenses 136 M
Operating Income -82.4 M
Other Expenses -1.65 M
Net Income -80.7 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 58.4 51.5 43.5 17.4 4.2 2.0 1.9 1.9 1.8 0.8 0 10 K
GROSS PROFIT
Cost Of Revenue 5.3 4.5 4.4 2.1 2.3 0.5 0.5 0.4 0.3 91 K 10.5 7 K
Gross Profit 53.2 47.0 39.1 15.3 1.9 1.5 1.5 1.4 1.4 0.7 (10.5) 3 K
OPERATING INCOME
Operating Expenses 135.5 125.6 117.2 78.2 87.7 60.6 63.4 44.8 39.6 27.8 12.9 13.7
Selling, General and Administrative Expenses 74.5 72.1 67.1 49.5 46.6 23.7 32.5 17.7 13.0 8.9 2.4 2.1
Research and Development Expenses 61.1 53.5 50.1 28.7 41.1 36.9 30.9 27.1 26.6 18.9 10.5 11.5
Operating Income (82.4) (78.7) (78.0) (62.8) (85.8) (59.1) (61.9) (43.3) (38.2) (27.1) (12.9) (13.7)
PRE-TAX INCOME
Interest Income Expense 11.3 7.0 6.7 6.8 6.1 1.7 1.9 1.7 1.7 1.1 0.4 0.4
Total Other Income 1.6 7.6 71.5 (92.8) (0.6) (0.9) (1.5) (1.4) (1.6) (1.6) (0.4) (0.4)
Pre-Tax Income (80.7) (71.0) (6.6) (155.6) (86.4) (60.0) (63.4) (44.7) (39.7) (28.6) (13.3) (14.1)
NET INCOME
Tax Provision 0 (7.6) 4.3 4.0 3.6 (2.3) 0.3 0.8 1.0 0.1 0.5 0.3
Net Income (80.7) (63.4) (10.8) (159.6) (89.9) (57.7) (63.4) (44.7) (39.7) (28.6) (13.3) (14.1)
EPS 1.09 0.83 0.14 2.63 1.99 1.51 2.2 1.8 1.71 2.69 4.51 4.77